Dr. Savania Nagiah (Nelson Mandela University) is a medical biochemist with a PhD from the University of KwaZulu-Natal (2017). Her research expertise is in antiretroviral drug-associated metabolic disorders. She managed the curation, implementation, and design of the basic medical science components of the MBChB curriculum at the new Nelson Mandela University Medical School in 2019/2020. She was inducted into the South African Young Academy of Science (SAYAS) in 2022 and was identified as an early career researcher by the Royal Society to attend the Commonwealth Science Conference in Singapore. This led to follow-on grants in collaboration with the University of Queensland (2017–2019). Dr. Nagiah has secured NRF emerging researcher seed funding (2022-2025) and holds a Y2 rating from the NRF.